Bertram Wiedenmann
#114,467
Most Influential Person Now
Researcher
Bertram Wiedenmann's AcademicInfluence.com Rankings
Bertram Wiedenmanncomputer-science Degrees
Computer Science
#4427
World Rank
#4663
Historical Rank
Machine Learning
#860
World Rank
#872
Historical Rank
Artificial Intelligence
#1067
World Rank
#1086
Historical Rank
Database
#1643
World Rank
#1723
Historical Rank
Download Badge
Computer Science
Bertram Wiedenmann's Degrees
- PhD Computer Science Stanford University
- Masters Computer Science University of California, Berkeley
- Bachelors Computer Science University of California, Berkeley
Similar Degrees You Can Earn
Why Is Bertram Wiedenmann Influential?
(Suggest an Edit or Addition)Bertram Wiedenmann's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. (2011) (2225)
- TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system (2006) (1419)
- Identification and localization of synaptophysin, an integral membrane glycoprotein of Mr 38,000 characteristic of presynaptic vesicles (1985) (1394)
- TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system (2007) (948)
- A colorectal cancer classification system that associates cellular phenotype and responses to therapy (2013) (854)
- ENETS Consensus Guidelines for the Management of Patients with Liver and Other Distant Metastases from Neuroendocrine Neoplasms of Foregut, Midgut, Hindgut, and Unknown Primary (2011) (789)
- Daily Oral Everolimus Activity in Patients with Metastatic Pancreatic Neuroendocrine Tumors after Failure of Cytotoxic Chemotherapy: A Phase II Trial (2010) (647)
- Consensus report on the use of somatostatin analogs for the management of neuroendocrine tumors of the gastroenteropancreatic system. (2004) (561)
- Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands (2001) (510)
- Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors--the International Lanreotide and Interferon Alfa Study Group. (2003) (479)
- Synaptophysin: a marker protein for neuroendocrine cells and neoplasms. (1986) (438)
- TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study. (2012) (429)
- ENETS Consensus Guidelines for High-Grade Gastroenteropancreatic Neuroendocrine Tumors and Neuroendocrine Carcinomas (2016) (419)
- Comparison of adefovir and tenofovir in the treatment of lamivudine‐resistant hepatitis B virus infection (2004) (405)
- Differentiation of pluripotent embryonic stem cells into the neuronal lineage in vitro gives rise to mature inhibitory and excitatory neurons (1995) (405)
- Prognostic relevance of a novel TNM classification system for upper gastroenteropancreatic neuroendocrine tumors (2008) (384)
- Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis (2008) (378)
- Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours. (2008) (368)
- Long‐term efficacy of tenofovir monotherapy for hepatitis B virus‐monoinfected patients after failure of nucleoside/nucleotide analogues (2010) (346)
- Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan (2010) (341)
- Synaptophysin and chromogranins/secretogranins widespread constituents of distinct types of neuroendocrine vesicles and new tools in tumor diagnosis (1989) (341)
- Guidelines for the Diagnosis and Treatment of Neuroendocrine Gastrointestinal Tumours (2004) (323)
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Towards a Standardized Approach to the Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors and Their Prognostic Stratification (2008) (319)
- Prediction of treatment outcome in patients with chronic hepatitis C: Significance of baseline parameters and viral dynamics during therapy (2002) (311)
- Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis. (2003) (310)
- Tenofovir for patients with lamivudine‐resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapy (2006) (303)
- Transport route for synaptobrevin via a novel pathway of insertion into the endoplasmic reticulum membrane. (1995) (290)
- Atu027, a liposomal small interfering RNA formulation targeting protein kinase N3, inhibits cancer progression. (2008) (288)
- A prospective randomised study on narrow-band imaging versus conventional colonoscopy for adenoma detection: does narrow-band imaging induce a learning effect? (2007) (284)
- Neuroendocrine tumors of midgut and hindgut origin: Tumor‐node‐metastasis classification determines clinical outcome (2011) (279)
- Molecular characterization of synaptophysin, a major calcium‐binding protein of the synaptic vesicle membrane. (1986) (273)
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine and Hybrid Imaging (2017) (267)
- Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors – Well-Differentiated Jejunal-Ileal Tumor/Carcinoma (2007) (261)
- Synaptophysin expression in neuroendocrine neoplasms as determined by immunocytochemistry. (1987) (246)
- Activated signal transducer and activator of transcription 3 (STAT3) supports the malignant phenotype of human pancreatic cancer. (2003) (246)
- Variants in CPA1 are strongly associated with early onset chronic pancreatitis (2013) (244)
- Well-Differentiated Pancreatic Tumor/Carcinoma: Insulinoma (2007) (239)
- A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitis (2006) (229)
- Endoscopic ultrasonography and somatostatin receptor scintigraphy in the preoperative localisation of insulinomas and gastrinomas. (1996) (223)
- Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and protectin formation. (2012) (219)
- The majority of intestinal IgA+ and IgG+ plasmablasts in the human gut are antigen-specific. (2011) (215)
- Factors determining the quality of screening colonoscopy: a prospective study on adenoma detection rates, from 12 134 examinations (Berlin colonoscopy project 3, BECOP-3) (2012) (214)
- Clathrin-coated vesicles contain an ATP-dependent proton pump. (1983) (210)
- De novo expression of vascular endothelial growth factor in human pancreatic cancer: evidence for an autocrine mitogenic loop. (2000) (199)
- Human Galectin-2: Novel Inducer of T Cell Apoptosis with Distinct Profile of Caspase Activation1 (2004) (197)
- Synaptophysin: a novel marker for neurons, certain neuroendocrine cells, and their neoplasms. (1986) (195)
- Tacrolimus Is Safe and Effective in Patients with Severe Steroid-Refractory or Steroid-Dependent Inflammatory Bowel Disease—A Long-Term Follow-Up (2006) (192)
- Insulin-like growth factor-I is an autocrine regulator of chromogranin A secretion and growth in human neuroendocrine tumor cells. (2000) (191)
- Oxidative Stress Regulates Vascular Endothelial Growth Factor-A Gene Transcription through Sp1- and Sp3-dependent Activation of Two Proximal GC-rich Promoter Elements* (2003) (190)
- Escherichia coli Strain Nissle 1917 Ameliorates Experimental Colitis via Toll-Like Receptor 2- and Toll-Like Receptor 4-Dependent Pathways (2006) (184)
- Pancreatic acinar cell carcinoma. An analysis of cell lineage markers, p53 expression, and Ki-ras mutation. (1993) (183)
- Neuroendocrine neoplasms of the gut and pancreas: new insights (2012) (178)
- Pasireotide (SOM230) shows efficacy and tolerability in the treatment of patients with advanced neuroendocrine tumors refractory or resistant to octreotide LAR: results from a phase II study. (2012) (175)
- Role of Stress in Functional Gastrointestinal Disorders (2001) (174)
- Transforming growth factor beta 1 stimulates vascular endothelial growth factor gene transcription in human cholangiocellular carcinoma cells. (2003) (168)
- Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity. (2008) (162)
- Desacyl ghrelin inhibits the orexigenic effect of peripherally injected ghrelin in rats (2008) (159)
- Sustained virological response in hepatitis C virus type 1b infected patients is predicted by the number of mutations within the NS5A-ISDR: a meta-analysis focused on geographical differences (2004) (158)
- Role of stress in functional gastrointestinal disorders. Evidence for stress-induced alterations in gastrointestinal motility and sensitivity. (2001) (153)
- Galectin-1 Interacts with the α5β1 Fibronectin Receptor to Restrict Carcinoma Cell Growth via Induction of p21 and p27* (2005) (153)
- Magnetic resonance cholangiopancreatography-guided unilateral endoscopic stent placement for Klatskin tumors. (2001) (152)
- Dual mechanism of vascular endothelial growth factor upregulation by hypoxia in human hepatocellular carcinoma (2001) (151)
- Rapid and Sustained Relief from the Symptoms of Carcinoid Syndrome: Results from an Open 6-Month Study of the 28-Day Prolonged-Release Formulation of Lanreotide (2004) (149)
- Tumor suppressor p16INK4a − modulator of glycomic profile and galectin‐1 expression to increase susceptibility to carbohydrate‐dependent induction of anoikis in pancreatic carcinoma cells (2007) (147)
- Improving compliance to colorectal cancer screening using blood and stool based tests in patients refusing screening colonoscopy in Germany (2014) (147)
- Prospective evaluation of pancreatic tumors: accuracy of MR imaging with MR cholangiopancreatography and MR angiography. (2002) (145)
- Escherichia coli Nissle 1917 Distinctively Modulates T-Cell Cycling and Expansion via Toll-Like Receptor 2 Signaling (2005) (143)
- Stromal R-spondin orchestrates gastric epithelial stem cells and gland homeostasis (2017) (139)
- Interferon γ inhibits growth of human pancreatic carcinoma cells via caspase-1 dependent induction of apoptosis (2001) (139)
- Narrow-band versus white-light high definition television endoscopic imaging for screening colonoscopy: a prospective randomized trial. (2009) (139)
- Pre-therapeutic dosimetry and biodistribution of 86Y-DOTA-Phe1-Tyr3-octreotide versus 111In-pentetreotide in patients with advanced neuroendocrine tumours (2004) (137)
- Survival and Clinical Outcome of Patients with Neuroendocrine Tumors of the Gastroenteropancreatic Tract in a German Referral Center (2004) (137)
- Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells (2005) (134)
- Rescue therapy with tacrolimus is effective in patients with severe and refractory inflammatory bowel disease (2003) (133)
- A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors (2018) (133)
- Endoscopic Ultrasonography of Neuroendocrine Tumours (2000) (132)
- A Cross-Species Analysis in Pancreatic Neuroendocrine Tumors Reveals Molecular Subtypes with Distinctive Clinical, Metastatic, Developmental, and Metabolic Characteristics. (2015) (129)
- A multicenter, phase II study of infliximab plus gemcitabine in pancreatic cancer cachexia. (2008) (129)
- Gastric hyperplasia in mice with targeted disruption of the carbonic anhydrase gene Car9. (2002) (123)
- Impact of Multiphase 68Ga-DOTATOC-PET/CT on Therapy Management in Patients with Neuroendocrine Tumors (2009) (122)
- Impact of pain on health-related quality of life in patients with inflammatory bowel disease. (2010) (122)
- Analysis of sporadic neuroendocrine tumours of the enteropancreatic system by comparative genomic hybridisation (2001) (121)
- An outbreak of carbapenem-resistant OXA-48 – producing Klebsiella pneumonia associated to duodenoscopy (2015) (120)
- Autoregulation of Th1-mediated inflammation by twist1 (2008) (119)
- EUS-guided FNA of solid pancreatic masses: high yield of 2 passes with combined histologic-cytologic analysis. (2009) (119)
- Clinical Relevance of Transabdominal Ultrasonography and Magnetic Resonance Imaging in Patients With Inflammatory Bowel Disease of the Terminal Ileum and Large Bowel (2004) (118)
- Regulatory peptide receptors in human hepatocellular carcinomas (1999) (118)
- Ultra-High-Dose Lanreotide Treatment in Patients with Metastatic Neuroendocrine Gastroenteropancreatic Tumors (1999) (117)
- Synthesis, characterization, and biological properties of cyanine-labeled somatostatin analogues as receptor-targeted fluorescent probes. (2001) (116)
- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Biochemical Markers (2017) (116)
- Characterization of somatostatin receptor subtype-specific regulation of insulin and glucagon secretion: an in vitro study on isolated human pancreatic islets. (2007) (114)
- Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2. (1996) (111)
- [S3-Guidelines "Exocrine pancreatic cancer" 2007]. (2007) (109)
- Hypoxia-Inducible Factor 1α Determines Gastric Cancer Chemosensitivity via Modulation of p53 and NF-κB (2010) (109)
- Localisation of neuroendocrine tumours of the upper gastrointestinal tract. (1994) (106)
- Telotristat etiprate for carcinoid syndrome: a single-arm, multicenter trial. (2015) (105)
- Galectin-4 Controls Intestinal Inflammation by Selective Regulation of Peripheral and Mucosal T Cell Apoptosis and Cell Cycle (2008) (104)
- Vascular endothelial growth factor-D induces lymphangiogenesis and lymphatic metastasis in models of ductal pancreatic cancer. (2005) (101)
- LI-cadherin: a marker of gastric metaplasia and neoplasia (2001) (101)
- Vascular endothelial growth factor receptor tyrosine kinase inhibitors: PTK787/ZK 222584. (2003) (101)
- A Toll-like receptor 7 single nucleotide polymorphism protects from advanced inflammation and fibrosis in male patients with chronic HCV-infection. (2007) (101)
- Streptozocin/5-fluorouracil chemotherapy is associated with durable response in patients with advanced pancreatic neuroendocrine tumours. (2015) (100)
- A Novel Function for the Tumor Suppressor p16INK4a (2000) (99)
- The German NET-Registry: An Audit on the Diagnosis and Therapy of Neuroendocrine Tumors (2009) (97)
- Adalimumab prevents barrier dysfunction and antagonizes distinct effects of TNF-α on tight junction proteins and signaling pathways in intestinal epithelial cells. (2013) (97)
- Intraperitoneal injection of ghrelin induces Fos expression in the paraventricular nucleus of the hypothalamus in rats (2003) (96)
- Mutations in the MEN I gene in sporadic neuroendocrine tumours of gastroenteropancreatic system (1997) (96)
- Galectin-2 induces apoptosis of lamina propria T lymphocytes and ameliorates acute and chronic experimental colitis in mice (2008) (95)
- mTOR expression and activity patterns in gastroenteropancreatic neuroendocrine tumours. (2011) (95)
- Somatostatin-receptor imaging of neuroendocrine gastroenteropancreatic tumors. (1993) (94)
- Helicobacter pylori stimulates host cyclooxygenase‐2 gene transcription: critical importance of MEK/ERK‐dependent activation of USF1/‐2 and CREB transcription factors (2003) (94)
- CCK inhibits the orexigenic effect of peripheral ghrelin. (2005) (93)
- Activation of protein kinase Calpha inhibits growth of pancreatic cancer cells via p21(cip)-mediated G(1) arrest. (2000) (93)
- 68Ga-DOTATOC PET/CT of Neuroendocrine Tumors: Spotlight on the CT Phases of a Triple-Phase Protocol (2011) (92)
- Orexin A stimulates glucose uptake, lipid accumulation and adiponectin secretion from 3T3-L1 adipocytes and isolated primary rat adipocytes (2011) (91)
- Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future (2019) (91)
- Hypoxia-inducible factor 1alpha mediates anoikis resistance via suppression of alpha5 integrin. (2008) (90)
- Mutation profiling of tumor DNA from plasma and tumor tissue of colorectal cancer patients with a novel, high-sensitivity multiplexed mutation detection platform (2014) (90)
- A motor-driven single-use colonoscope controlled with a hand-held device: a feasibility study in volunteers. (2008) (87)
- Topogenesis and sorting of synaptophysin: Synthesis of a synaptic vesicle protein from a gene transfected into nonneuroendocrine cells (1989) (86)
- Axon guidance factor SLIT2 inhibits neural invasion and metastasis in pancreatic cancer. (2014) (86)
- Neuroendocrine tumors. Biotherapy. (2007) (86)
- ENETS 2011 Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors: An Update (2011) (85)
- Interferon‐α delays S‐phase progression in human hepatocellular carcinoma cells via inhibition of specific cyclin‐dependent kinases (2001) (84)
- Peripheral injection of ghrelin induces Fos expression in the dorsomedial hypothalamic nucleus in rats (2006) (83)
- Identification of gastroenteropancreatic neuroendocrine cells in normal and neoplastic human tissue with antibodies against synaptophysin, chromogranin A, secretogranin I (chromogranin B), and secretogranin II. (1988) (82)
- HIF-1α determines the metastatic potential of gastric cancer cells (2009) (82)
- Vesicular monoamine transporter 2 as a marker of gastric enterochromaffin-like cell tumors (2000) (81)
- Glucagon increases circulating fibroblast growth factor 21 independently of endogenous insulin levels: a novel mechanism of glucagon-stimulated lipolysis? (2013) (79)
- Angiopoietin-2 Promotes Disease Progression of Neuroendocrine Tumors (2010) (79)
- Tumor-Associated Angiogenesis and Lymphangiogenesis Correlate With Progression of Intrahepatic Cholangiocarcinoma (2010) (78)
- Molecular Pathogenesis of Neuroendocrine Tumors: Implications for Current and Future Therapeutic Approaches (2013) (78)
- Effect of intraperitoneal recombinant human tumour necrosis factor alpha on malignant ascites. (1991) (78)
- Oxidative Stress Activates the Human Histidine Decarboxylase Promoter in AGS Gastric Cancer Cells* (1998) (76)
- Detection of G-protein heterotrimers on large dense core and small synaptic vesicles of neuroendocrine and neuronal cells. (1994) (76)
- Diagnosis of neuroendocrine tumours by retrospective image fusion: is there a benefit? (2004) (75)
- Nerve growth factor stimulates clonal growth of human lung cancer cell lines and a human glioblastoma cell line expressing high-affinity nerve growth factor binding sites involving tyrosine kinase signaling. (1995) (74)
- Enhanced innate immune responsiveness and intolerance to intestinal endotoxins in human biliary epithelial cells contributes to chronic cholangitis (2011) (73)
- Helicobacter pylori Activates the Histidine Decarboxylase Promoter through a Mitogen-activated Protein Kinase Pathway Independent of Pathogenicity Island-encoded Virulence Factors* (2000) (73)
- The Targeted Immunocytokine L19-IL2 Efficiently Inhibits the Growth of Orthotopic Pancreatic Cancer (2008) (73)
- Helicobacter pylori stimulates host vascular endothelial growth factor‐A (vegf‐A) gene expression via MEK/ERK‐dependent activation of Sp1 and Sp3 (2004) (73)
- Molecular Mechanisms of Enteroendocrine Differentiaton (1998) (72)
- Galectin‐2 and ‐4, but not Galectin‐1, promote intestinal epithelial wound healing in vitro through a TGF‐beta‐independent mechanism (2008) (72)
- Malnutrition Predicts Clinical Outcome in Patients with Neuroendocrine Neoplasia (2015) (72)
- Association of TLR7 single nucleotide polymorphisms with chronic HCV‐infection and response to interferon‐a‐based therapy (2007) (72)
- Competitive Testing of the WHO 2010 versus the WHO 2017 Grading of Pancreatic Neuroendocrine Neoplasms: Data from a Large International Cohort Study (2018) (71)
- Mutations in the E2‐PePHD and NS5A region of hepatitis C virus type 1 and the dynamics of hepatitis C viremia decline during interferon alfa treatment (2000) (71)
- Evaluation of endocytoscopy in the surveillance of patients with Barrett's esophagus. (2007) (71)
- Differential induction of c-fos expression in brain nuclei by noxious and non-noxious colonic distension: role of afferent C-fibers and 5-HT3 receptors (2003) (70)
- Angiopoietin‐2 drives lymphatic metastasis of pancreatic cancer (2011) (70)
- ENETS Consensus Guidelines for the Management of Bone and Lung Metastases from Neuroendocrine Tumors (2010) (69)
- CXCL8 modulates human intestinal epithelial cells through a CXCR1 dependent pathway. (2004) (69)
- Synaptophysin expressed in the bronchopulmonary tract: neuroendocrine cells, neuroepithelial bodies, and neuroendocrine neoplasms. (1987) (68)
- Immunoelectron microscopic localization of synaptophysin in a golgi subcompartment of developing hypothalamic neurons (1988) (68)
- Molecular mechanism of interferon alfa-mediated growth inhibition in human neuroendocrine tumor cells. (2000) (68)
- Anti-ghrelin Spiegelmer NOX-B11 inhibits neurostimulatory and orexigenic effects of peripheral ghrelin in rats (2005) (67)
- Influence of interleukin 12B (IL12B) polymorphisms on spontaneous and treatment-induced recovery from hepatitis C virus infection. (2004) (67)
- Differential priming of CD8 and CD4 T‐cells in animal models of autoimmune hepatitis and cholangitis (2007) (66)
- Retinoids: effects on growth, differentiation, and nuclear receptor expression in human pancreatic carcinoma cell lines. (1995) (66)
- Lipoxins and resolvins in inflammatory bowel disease. (2007) (65)
- Synaptophysin: A New Marker for Pancreatic Neuroendocrine Tumors (1987) (65)
- [Biologic therapy of inflammatory bowel disease]. (2003) (64)
- Molecular and cell biological aspects of neuroendocrine tumors of the gastroenteropancreatic system (1998) (64)
- Loss of the coxsackie and adenovirus receptor contributes to gastric cancer progression (2009) (63)
- An amphicrine pancreatic cell line: AR42J cells combine exocrine and neuroendocrine properties. (1992) (63)
- Glucocorticoids regulate barrier function and claudin expression in intestinal epithelial cells via MKP-1. (2014) (60)
- Angiopoietin-2 Serum Levels Are Elevated in Patients With Liver Cirrhosis and Hepatocellular Carcinoma (2007) (60)
- Safety and efficacy of pasireotide (SOM230) in patients with metastatic carcinoid tumors refractory or resistant to octreotide LAR: Results of a phase II study. (2006) (59)
- Novel insight in distribution of nesfatin-1 and phospho-mTOR in the arcuate nucleus of the hypothalamus of rats (2010) (59)
- VEGF‐D promotes tumor growth and lymphatic spread in a mouse model of hepatocellular carcinoma (2008) (59)
- Electrogastrography as a diagnostic tool for delayed gastric emptying in functional dyspepsia and irritable bowel syndrome (2003) (58)
- Health-Related Quality of Life in Patients with Pancreatic Cancer (2007) (58)
- Sp1 and CREB Mediate Gastrin-dependent Regulation of Chromogranin A Promoter Activity in Gastric Carcinoma Cells* (1998) (57)
- Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors: Why Such Guidelines and How We Went about It (2007) (57)
- A novel function for the tumor suppressor p16(INK4a): induction of anoikis via upregulation of the alpha(5)beta(1) fibronectin receptor. (2000) (57)
- CCK-8S activates c-Fos in a dose-dependent manner in nesfatin-1 immunoreactive neurons in the paraventricular nucleus of the hypothalamus and in the nucleus of the solitary tract of the brainstem (2009) (56)
- Orexin-A inhibits glucagon secretion and gene expression through a Foxo1-dependent pathway. (2008) (56)
- Latest generation, wide-angle, high-definition colonoscopes increase adenoma detection rate. (2012) (55)
- ClC-3 expression enhances etoposide resistance by increasing acidification of the late endocytic compartment (2007) (55)
- Drug therapy in metastatic neuroendocrine tumors of the gastroenteropancreatic system. (1996) (54)
- Interaction of early growth response protein 1 (Egr-1), specificity protein 1 (Sp1), and cyclic adenosine 3'5'-monophosphate response element binding protein (CREB) at a proximal response element is critical for gastrin-dependent activation of the chromogranin A promoter. (2002) (54)
- Synaptobrevin is essential for secretion but not for the development of synaptic processes. (1996) (52)
- Solubilization of proteins from bovine brain coated vesicles by protein perturbants and Triton X-100 (1985) (52)
- Long-term failure of endoscopic suturing in the treatment of gastroesophageal reflux: a prospective follow-up study. (2005) (51)
- Dual mechanism of vascular endothelial growth factor upregulation by hypoxia in human hepatocellular carcinoma. (2000) (51)
- A phase IB, open-label dose-escalating study of the oral angiogenesis inhibitor PTK787/ZK 222584 (PTK/ZK), in combination with FOLFOX4 chemotherapy in patients with advanced colorectal cancer. (2006) (51)
- Diagnostic and therapeutic single-operator cholangiopancreatoscopy with SpyGlassDS™: results of a multicenter retrospective cohort study (2018) (51)
- The probiotic Escherichia coli strain Nissle 1917 induces gammadelta T cell apoptosis via caspase- and FasL-dependent pathways. (2008) (50)
- Uneventful pregnancy and neonatal outcome with tacrolimus in refractory ulcerative colitis (2005) (50)
- Impact of FDG-PET/MRI Image Fusion on the Detection of Pancreatic Cancer (2007) (50)
- Obestatin in human neuroendocrine tissues and tumours: expression and effect on tumour growth (2009) (50)
- A complete substitutional analysis of VIP for better tumor imaging properties (2002) (49)
- Is desacyl ghrelin a modulator of food intake? (2009) (49)
- Association of CTLA4 single nucleotide polymorphisms with viral but not autoimmune liver disease (2007) (49)
- Vasoactive intestinal peptide receptor scintigraphy in patients with pancreatic adenocarcinomas or neuroendocrine tumours (2000) (49)
- γ-Aminobutyric acid secretion from pancreatic neuroendocrine cells (1996) (48)
- Gender-dependent association of CTLA4 polymorphisms with resolution of hepatitis C virus infection. (2007) (48)
- Impact of Octreotide Long-Acting Release on Tumour Growth Control as a First-Line Treatment in Neuroendocrine Tumours of Pancreatic Origin (2013) (48)
- Effects of orexin A on proliferation, survival, apoptosis and differentiation of 3T3‐L1 preadipocytes into mature adipocytes (2012) (48)
- Peripheral obestatin has no effect on feeding behavior and brain Fos expression in rodents (2008) (47)
- [Practice guideline neuroendocrine tumors - AWMF-Reg. 021-27]. (2018) (46)
- A matter of the heart: myocardial metastases in neuroendocrine tumors. (2010) (46)
- Refractory Sprue Syndrome with Clonal Intraepithelial Lymphocytes Evolving into Overt Enteropathy-Type Intestinal T-Cell Lymphoma (2000) (46)
- Increased T-helper 2 cytokines in bile from patients with IgG4-related cholangitis disrupt the tight junction-associated biliary epithelial cell barrier. (2013) (45)
- Diagnosis of Non-Functioning Neuro-Endocrine Gastro-Enteropancreatic Tumours (2004) (45)
- B‐Raf/Rap1 signaling, but not c‐Raf‐1/Ras, induces the histidine decarboxylase promoter in Helicobacter pylori infection (2002) (45)
- Tumor-Associated Lymphangiogenesis Correlates with Lymph Node Metastases and Prognosis in Hilar Cholangiocarcinoma (2008) (44)
- Treatment of the carcinoid syndrome with a depot formulation of the somatostatin analogue lanreotide. (1994) (44)
- The impact of elevated serum IgG4 levels in patients with primary sclerosing cholangitis. (2014) (44)
- Endosonography of Neuroendocrine Tumors of the Stomach, Duodenum, and Pancreas (1994) (43)
- Galectins distinctively regulate central monocyte and macrophage function. (2011) (43)
- R-spondin-3 induces secretory, antimicrobial Lgr5+ cells in the stomach (2019) (43)
- Synaptophysin identified in metastases of neuroendocrine tumors by immunocytochemistry and immunoblotting. (1987) (43)
- Combined imaging techniques for pancreatic cancer (2000) (42)
- Microvessel density correlates with lymph node metastases and prognosis in hilar cholangiocarcinoma (2008) (42)
- Dynamics of GB Virus C viremia early after orthotopic liver transplantation indicates extrahepatic tissues as the predominant site of GB virus C replication (1999) (42)
- Appropriateness of Colonoscopy in the Era of Colorectal Cancer Screening: A Prospective, Multicenter Study in a Private-Practice Setting (Berlin Colonoscopy Project 1, BECOP 1) (2007) (42)
- Treatment of gastroenteropancreatic neuroendocrine tumors (2007) (42)
- Activin A stimulates vascular endothelial growth factor gene transcription in human hepatocellular carcinoma cells. (2004) (42)
- Proteomic Analysis of the Inflamed Intestinal Mucosa Reveals Distinctive Immune Response Profiles in Crohn’s Disease and Ulcerative Colitis1 (2007) (41)
- Primary and secondary hepatic manifestation of neuroendocrine tumors (2000) (41)
- Oesophageal transport of solid dosage forms depends on body position, swallowing volume and pharyngeal propulsion velocity (2004) (41)
- Decrease of natural killer cell activity and monokine production in peripheral blood of patients treated with recombinant tumor necrosis factor. (1988) (41)
- Sorting of synaptophysin into special vesicles in nonneuroendocrine epithelial cells (1994) (41)
- EndoClot Polysaccharide Hemostatic System in Nonvariceal Gastrointestinal Bleeding: Results of a Prospective Multicenter Observational Pilot Study (2016) (41)
- Influence of hepatic dysfunction on safety, tolerability, and pharmacokinetics (PK) of PTK787/ZK 222584 in patients (Pts) with unresectable hepatocellular carcinoma (HCC) (2005) (40)
- Secretin receptors in the human liver: expression in biliary tract and cholangiocarcinoma, but not in hepatocytes or hepatocellular carcinoma. (2006) (40)
- Transient Receptor Potential Channel TRPM8 Agonists Stimulate Calcium Influx and Neurotensin Secretion in Neuroendocrine Tumor Cells (2007) (40)
- Stage IV Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: A Risk Score to Predict Clinical Outcome. (2017) (40)
- Somatostatin receptor subtype-2-deficient mice with diet-induced obesity have hyperglycemia, nonfasting hyperglucagonemia, and decreased hepatic glycogen deposition. (2007) (39)
- The amphicrine pancreatic cell line, AR42J, secretes GABA and amylase by separate regulated pathways (1992) (39)
- ENETS Consensus Guidelines for the Standard of Care in Neuroendocrine Tumors (2009) (39)
- p53 tumour suppressor gene expression in pancreatic neuroendocrine tumour cells. (1996) (39)
- Role of hypoxia-inducible transcription factor 1α for progression and chemosensitivity of murine hepatocellular carcinoma (2010) (38)
- Expression of neuroendocrine markers (neuronspecific enolase, synaptophysin and bombesin) in carcinoma of the lung. (1988) (38)
- Serum chromogranin A in the diagnosis and follow-up of neuroendocrine tumors of the gastroenteropancreatic tract (1992) (38)
- Dominant negative action of an abnormal secretin receptor arising from mRNA missplicing in a gastrinoma. (2002) (37)
- Thermo-sensitive transient receptor potential vanilloid channel-1 regulates intracellular calcium and triggers chromogranin A secretion in pancreatic neuroendocrine BON-1 tumor cells. (2012) (37)
- Management and outcomes of haemorrhage after pancreatogastrostomy versus pancreatojejunostomy (2011) (37)
- Enteral and parenteral nutrition distinctively modulate intestinal permeability and T cell function in vitro (2009) (37)
- Autocrine growth inhibition by transforming growth factor β-1 (TGFβ-1) in human neuroendocrine tumour cells (2003) (37)
- Gastric Perception Thresholds Are Low and Sensory Neuropeptide Levels High in Helicobacter pylori-Positive Functional Dyspepsia (2005) (36)
- Neuroendocrine Tumors of the Gastro-Entero-Pancreatic System: The Role of Early Diagnosis, Genetic Testing and Preventive Surgery (2002) (36)
- Successful recanalization of a completely obliterated esophageal stricture by using an endoscopic rendezvous maneuver. (2005) (36)
- Multiple Endocrine Neoplasia Type 1 and the Pancreas: Diagnosis and Treatment of Functioning and Non-Functioning Pancreatic and Duodenal Neuroendocrine Neoplasia within the MEN1 Syndrome – An International Consensus Statement (2020) (36)
- Overexpression of pRB in human pancreatic carcinoma cells: function in chemotherapy-induced apoptosis. (2002) (36)
- Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors: The Second Event and Some Final Considerations (2007) (36)
- Cyanine Dye Labeled Vasoactive Intestinal Peptide and Somatostatin Analog for Optical Detection of Gastroenteropancreatic Tumors (2000) (35)
- Surgery with Radical Intent: Is There an Indication for G3 Neuroendocrine Neoplasms? (2019) (35)
- Downregulation of p21waf/cip-1 mediates apoptosis of human hepatocellular carcinoma cells in response to interferon-γ (2003) (35)
- Probiotic carbohydrates reduce intestinal permeability and inflammation in metabolic diseases (2009) (35)
- Interferon-alpha delays S-phase progression in human hepatocellular carcinoma cells via inhibition of specific cyclin-dependent kinases. (2001) (35)
- Vascular endothelial growth factor receptor tyrosine kinase inhibitors: PTK787/ZK 222584 (2003) (35)
- The oral multitarget tumour growth inhibitor, ZK 304709, inhibits growth of pancreatic neuroendocrine tumours in an orthotopic mouse model (2008) (35)
- Data quality of the German Screening Colonoscopy Registry (2013) (34)
- From Targets to Treatments: A Review of Molecular Targets in Pancreatic Neuroendocrine Tumors (2011) (34)
- Mesalamine promotes intestinal epithelial wound healing in vitro through a TGF-beta-independent mechanism (2005) (34)
- Occurrence of a novel DNA virus (TTV) infection in patients with liver diseases and its frequency in blood donors (1999) (34)
- Pasireotide ( SOM 230 ) shows efficacy and tolerability in the treatment of patients with advanced neuroendocrine tumors refractory or resistant to octreotide LAR : results from a phase II study (2012) (33)
- Neuroendocrine neoplasia of the gastrointestinal tract revisited: towards precision medicine (2020) (33)
- Two immunocytochemical protocols for immunofluorescent detection of c-Fos positive neurons in the rat brain. (2004) (33)
- Development of ulcerative colitis in a patient with multiple sclerosis following treatment with interferon beta 1a. (2007) (33)
- Management of metastatic endocrine tumours (2005) (33)
- Apolipoprotein E4 allele is associated with poor treatment response in hepatitis C virus (HCV) genotype 1 (2003) (32)
- Development of G Protein‐mediated Ca2+ Channel Regulation in Mouse Embryonic Stem Cell‐derived Neurons (1997) (32)
- Successful Therapy of Refractory Pyoderma Gangrenosum and Periorbital Phlegmona With Tacrolimus (FK506) in Ulcerative Colitis (2004) (32)
- Diagnosis of enteroceles by dynamic anorectal endosonography (2000) (32)
- Peripheral injection of CCK-8S induces Fos expression in the dorsomedial hypothalamic nucleus in rats (2006) (32)
- Retinoic acid receptor alpha mediates growth inhibition by retinoids in human colon carcinoma HT29 cells. (1999) (32)
- Brief report: a duodenal gastrinoma in a patient with diarrhea and normal serum gastrin concentrations. (1995) (31)
- 8. Multidisciplinary Approach for the Treatment of Neuroendocrine Tumors (2010) (31)
- Electrophysiological properties of human carcinoid cells of the gut. (1997) (31)
- Placental growth factor supports neuroendocrine tumor growth and predicts disease prognosis in patients. (2013) (31)
- The c.1-260C>T Promoter Variant of CD14 but Not the c.896A>G (p.D299G) Variant of Toll-Like Receptor 4 (TLR4) Genes Is Associated with Inflammatory Bowel Disease (2007) (31)
- Downregulation of the coxsackie and adenovirus receptor in cancer cells by hypoxia depends on HIF-1α (2010) (31)
- Phase-I trial of intravenous continuous infusion of tumor necrosis factor in advanced metastatic carcinomas (2004) (30)
- Common biostructure of the colonic microbiota in neuroendocrine tumors and Crohn's disease and the effect of therapy (2012) (30)
- Synaptophysin. A widespread constituent of small neuroendocrine vesicles and a new tool in tumor diagnosis. (1991) (30)
- CapsoCam SV-1 Versus PillCam SB 3 in the Detection of Obscure Gastrointestinal Bleeding: Results of a Prospective Randomized Comparative Multicenter Study (2019) (30)
- Expanded phase I/II study of PTK787/ZK 222584 (PTK/ZK), a novel, oral angiogenesis inhibitor, in combination with FOLFOX-4 as first-line treatment for patients with metastatic colorectal cancer. (2004) (30)
- Experience with teduglutide treatment for short bowel syndrome in clinical practice. (2019) (29)
- Characterization of voltage operated R-type Ca2+ channels in modulating somatostatin receptor subtype 2- and 3-dependent inhibition of insulin secretion from INS-1 cells. (2008) (29)
- [Endoscopic therapy of ischemia-type biliary lesions in patients following orthotopic liver transplantation]. (1999) (28)
- Impact of the coxsackievirus and adenovirus receptor on the adenoma–carcinoma sequence of colon cancer (2011) (28)
- Gastroenteropancreatic tumor imaging with somatostatin receptor scintigraphy. (1994) (28)
- Distinct temporospatial expression patterns of glycolysis-related proteins in human hepatocellular carcinoma (2009) (28)
- Tumor-Associated Lymphangiogenesis Correlates with Prognosis after Resection of Human Hepatocellular Carcinoma (2009) (28)
- Functional Imaging in the Follow-Up of Enteropancreatic Neuroendocrine Tumors: Clinical Usefulness and Indications (2017) (27)
- Bombesin, but not amylin, blocks the orexigenic effect of peripheral ghrelin. (2006) (27)
- Inducible re-expression of p16 in an orthotopic mouse model of pancreatic cancer inhibits lymphangiogenesis and lymphatic metastasis (2008) (26)
- Octreotide Does Not Inhibit Proliferation in Five Neuroendocrine Tumor Cell Lines (2018) (26)
- Subcellular localization of secretogranin II and synaptophysin by immunoelectron microscopy in differentiated hypothalamic neurons in culture. (1991) (25)
- Open-label, non-randomized, multicenter phase II study evaluating the angiogenesis inhibitor PTK787/ ZK222584 (PTK/ZK) in patients with advanced neuroendocrine carcinomas (NEC) (2008) (25)
- The small GTP-binding protein, Rab6p, is associated with both Golgi and post-Golgi synaptophysin-containing membranes during synaptogenesis of hypothalamic neurons in culture. (1993) (25)
- Identification of a distinct 9S form of soluble clathrin in cultured cells and tissues. (1986) (25)
- Downregulation of p21(waf/cip-1) mediates apoptosis of human hepatocellular carcinoma cells in response to interferon-gamma. (2003) (25)
- Immortalized gonadotropin‐releasing hormone neurons secrete γ‐aminobutyric acid – evidence for an autocrine regulation (1998) (25)
- Immunoluminometric assay of chromogranin A in serum with commercially available reagents. (1992) (25)
- Autocrine growth inhibition by transforming growth factor beta-1 (TGFbeta-1) in human neuroendocrine tumour cells. (2003) (24)
- Systematic high-content proteomic analysis reveals substantial immunologic changes in colorectal cancer. (2008) (24)
- and galectin-1 expression to increase susceptibility to carbohydrate-dependent induction of anoikis in pancreatic carcinoma cells (2007) (23)
- DISTINCT ENZYME PROFILES IN PATIENTS WITH CRYPTOGENIC CIRRHOSIS REFLECT HETEROGENEOUS CAUSES WITH DIFFERENT OUTCOMES AFTER LIVER TRANSPLANTATION (OLT): A LONG-TERM DOCUMENTATION BEFORE AND AFTER OLT (2002) (23)
- Functional Relevance of Activin A in the Intestinal Epithelium (2002) (23)
- Direct and indirect costs in a prospective cohort of patients with pancreatic cancer (2005) (22)
- Nonsteroidal anti‐inflammatory drugs inhibit growth of human neuroendocrine tumor cells via G1 cell‐cycle arrest (2003) (22)
- Sp1 and CREB mediate gastrin-dependent regulation of chromogranin A promoter activity in gastric carcinoma cells. (1998) (22)
- All-trans-Retinoic Acid-mediated Growth Inhibition Involves Inhibition of Human Kinesin-related Protein HsEg5* (1999) (22)
- Evaluation of radiological prognostic factors of hepatic metastases in patients with non-functional pancreatic neuroendocrine tumors. (2013) (22)
- Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours (2020) (21)
- Pilot study of interferon-alpha high-dose induction therapy in combination with ribavirin plus amantadine for nonresponder patients with chronic hepatitis C. (2001) (21)
- ENETS Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors: Part 1 - Stomach, Duodenum and Pancreas (2007) (21)
- Differential expression and subcellular localization of secretogranin II and synaptophysin during early development of mouse hypothalamic neurons in culture (1992) (21)
- 73 A MULTICENTER ANALYSIS OF ANTIVIRAL RESPONSE AFTER ONE YEAR OF TENOFOVIR MONO-THERAPY IN HBV-MONOINFECTED PATIENTS WITH PRIOR NUCLEOS(T)IDE ANALOG EXPERIENCE (2008) (21)
- Hepatitis-C Patients Have Reduced Growth Hormone (GH) Secretion Which Improves During Long-Term Therapy With Pegylated Interferon-α (2007) (20)
- Activation of TRPV4 channel in pancreatic INS‐1E beta cells enhances glucose‐stimulated insulin secretion via calcium‐dependent mechanisms (2013) (20)
- Guanylin stimulates regulated secretion from human neuroendocrine pancreatic cells. (1998) (20)
- R-Type Ca2+-channel Activity Is Associated with Chromogranin A Secretion in Human Neuroendocrine Tumor BON Cells (2003) (19)
- Determinants of Quality of Life in Patients With Intestinal Failure Receiving Long-Term Parenteral Nutrition Using the SF-36 Questionnaire: A German Single-Center Prospective Observational Study. (2020) (19)
- Rescue therapy with tacrolimus in a patient with toxic megacolon (2003) (19)
- Neuroendocrine-specific and gastrin-dependent expression of a chromogranin A-luciferase fusion gene in transgenic mice. (2001) (19)
- Cardiac surgery for carcinoid heart disease in 12 cases (2011) (19)
- Syndromic versus non-syndromic sporadic gastrin-producing neuroendocrine tumors of the duodenum: comparison of pathological features and biological behavior (2016) (19)
- Molecular dissection of regulated secretory pathways in human gastric enterochromaffin-like cells: an immunohistochemical analysis (1999) (19)
- Open-label, non-randomised, inter-individual dose escalation of ZK 304709 with the evaluation of safety, tolerability, pharmacokinetics, oral bioavailability and orientating efficacy after daily administration in patients with advanced cancer (7 d treatment and 14 d recovery). (2008) (18)
- Prospective, randomized comparison of mechanical and electronic radial endoscopic ultrasound systems: Assessment of performance parameters and image quality (2009) (18)
- Interferon-alpha versus somatostatin or the combination of both in metastatic neuroendocrine gut and pancreatic tumours. (1996) (18)
- Radical intended surgery for highly selected stage IV neuroendocrine neoplasms G3. (2020) (18)
- Glucagon regulates orexin A secretion in humans and rodents (2014) (18)
- Peripherally injected CCK-8S activates CART positive neurons of the paraventricular nucleus in rats (2010) (18)
- Peritoneal Carcinomatosis in Gastro-Entero-Pancreatic Neuroendocrine Neoplasms: Clinical Impact and Effectiveness of the Available Therapeutic Options (2019) (17)
- Prospective pilot evaluation of a new needle prototype for endoscopic ultrasonography-guided fine-needle aspiration: comparison of cytology and histology yield (2008) (17)
- Unmet Medical Needs in Pulmonary Neuroendocrine (Carcinoid) Neoplasms (2018) (17)
- Loss of Coxsackie and adenovirus receptor downregulates α-catenin expression (2009) (17)
- Interactions of Gastrointestinal Peptides: Ghrelin and Its Anorexigenic Antagonists (2010) (17)
- Expression of functional GABAA receptors in neuroendocrine gastropancreatic cells (1995) (17)
- Management of Severe Refractory Adult Autoimmune Enteropathy with Infliximab and Tacrolimus (2005) (16)
- ENETS Consensus Guidelines for the Diagnosis and Treatment of Neuroendocrine Gastrointestinal Tumors: Part 2 - Midgut and Hindgut Tumors (2008) (16)
- A frequent keratin 8 p.L227L polymorphism, but no point mutations in keratin 8 and 18 genes, in patients with various liver disorders (2004) (16)
- Expression and function of the coxsackie and adenovirus receptor in Barrett's esophagus and associated neoplasia (2009) (16)
- Primary Neuroendocrine Neoplasms of the Breast: Case Series and Literature Review (2020) (16)
- Tubulin is a major protein constituent of bovine brain coated vesicles. (1983) (15)
- Extremely Long Survival under Combined Immunotherapy in a Metastatic Functional Neuroendocrine Neoplasia Patient (2017) (15)
- gamma-Aminobutyric acid secretion from pancreatic neuroendocrine cells. (1996) (15)
- Fra‐1: a novel target for retinoid action (1999) (15)
- Somatostatin Receptor Targeting for Tumor Imaging and Therapy (2004) (15)
- [Acute liver failure following the use of ecstasy (MDMA)]. (2002) (15)
- CD154, a marker of antigen‐specific stimulation of CD4 T cells, is associated with response to treatment in patients with chronic HCV infection (2011) (15)
- Early data on the efficacy and safety of the novel multi-ligand somatostatin analog, SOM230, in patients with metastatic carcinoid tumors refractory or resistant to octreotide LAR (2005) (15)
- Quantification in 68Ga-DOTA(0)-Phe(1)-Tyr(3)-Octreotide Positron Emission Tomography/Computed Tomography: Can We Be Impartial about Partial Volume Effects? (2013) (15)
- Somatostatin receptor subtypes in neuroendocrine tumor cell lines and tumor tissues (2004) (15)
- Interferon-γ inhibits growth of human neuroendocrine carcinoma cells via induction of apoptosis (2002) (14)
- Keratin 8 Y54H and G62C mutations are not associated with liver disease (2004) (14)
- Unmet needs in the international neuroendocrine tumor (NET) community: Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals (2019) (14)
- Neuroendocrine neoplasia goes molecular — time for a change (2018) (14)
- An Orthotopic Model of Pancreatic Somatostatin Receptor (SSTR)-Positive Tumors Allows Bimodal Imaging Studies Using 3T MRI and Animal PET-Based Molecular Imaging of SSTR Expression (2007) (14)
- Oxaliplatin plus 5-fluorouracil/folinic acid as palliative treatment for progressive malignant gastrointestinal neuroendocrine carcinomas. (2006) (14)
- Endocrine tumours of the gastrointestinal tract. Management of metastatic endocrine tumours. (2005) (14)
- Assessment and clinical implications of RANK/RANKL/OPG pathway as markers of bone tumor progression in patients with NET harboring bone metastases (2013) (14)
- p53 mutagenesis in Klatskin tumors. (1998) (14)
- Evaluation of complement factor 5 variants as genetic risk factors for the development of advanced fibrosis in chronic hepatitis C infection. (2008) (13)
- Insulinostatic activity of cerebellin — Evidence from in vivo and in vitro studies in rats (2009) (13)
- RAMSETE: A single-arm, multicenter, single-stage phase II trial of RAD001 (everolimus) in advanced and metastatic silent neuro-endocrine tumours in Europe. (2012) (13)
- Electrical Activity and Calcium Channels in Neuroendocrine Cells (1994) (13)
- [Current recommendations for surveillance, risk reduction and therapy in Lynch syndrome patients]. (2019) (13)
- The management of patients with neuroendocrine tumours. (2003) (13)
- Relevance of endotoxin receptor CD14 and TLR4 gene variants in chronic liver disease (2008) (13)
- Tumor suppressor p16INK4a controls oncogenic K‐Ras function in human pancreatic cancer cells (2012) (13)
- Insulin-Like Growth Factor-1 Increases Intracellular Calcium Concentration in Human Primary Neuroendocrine Pancreatic Tumor Cells and a Pancreatic Neuroendocrine Tumor Cell Line (BON-1) via R-Type Ca2+ Channels and Regulates Chromogranin A Secretion in BON-1 Cells (2006) (13)
- [Carcinoma of the pancreas: summary of guidelines 2007, issued jointly by 15 German specialist medical societies]. (2007) (13)
- PuraStat in gastrointestinal bleeding: results of a prospective multicentre observational pilot study (2021) (12)
- Staged Catheter-Based Valve Treatment of Severe Carcinoid Heart Disease (2015) (12)
- Adding interferon-alpha to octreotide slows tumour progression compared with octreotide alone but evidence is lacking for improved survival in people with disseminated midgut carcinoid tumours. (2003) (12)
- Consensus Guidelines for High Grade Gastro-Entero Pancreatic (GEP) Neuroendocrine Tumours and Neuroendocrine Carcinomas (NEC). (2016) (12)
- Analysis of the effect of IL-12 therapy on immunoregulatory T-cell subsets in patients with chronic hepatitis C infection. (2003) (12)
- Synaptophysin: A reliable marker for medulloblastomas (2004) (12)
- Tumour necrosis factor production and natural killer cell activity in peripheral blood during treatment with recombinant tumour necrosis factor. (1989) (12)
- A Prospective Pilot Study to Assess Technical Performance of a New Single Use Colonoscope with Inverted Sleeve Technology (2007) (12)
- Induction of T helper cell type 1 response and elimination of HBeAg during treatment with IL-12 in a patient with therapy-refractory chronic hepatitis B. (2001) (12)
- Systemic therapeutic strategies for GEP-NETS: what can we expect in the future? (2014) (12)
- Erratum: Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumors (Neuroendocrinology (2004) 80 (394-424)) (2005) (11)
- Multicenter Analysis of Treatment Outcomes for Systemic Therapy in Well Differentiated Grade 3 Neuroendocrine Tumors (NET G3) (2021) (11)
- Effect of hemoglobin A and S on human erythrocyte ghosts. (1983) (11)
- Sulfated cholecystokinin-8 activates phospho-mTOR immunoreactive neurons of the paraventricular nucleus in rats (2011) (11)
- Failure of CD4 T-Cells to Respond to Liver-Derived Antigen and to Provide Help to CD8 T-Cells (2011) (11)
- Endoscopy in Barrett’s oesophagus: adherence to standards and neoplasia detection in the community practice versus hospital setting (2008) (11)
- Novel Therapeutic Agents for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors (2011) (11)
- Expression of Functional GABAA Receptors in Isolated Human Insulinoma Cells (1998) (11)
- Models of Gastroenteropancreatic Neuroendocrine Neoplasms: Current Status and Future Directions (2020) (11)
- Ramsete : a single-arm, multicenter, single-stage phase ii trial of rad001 (everolimus) in advanced and metastatic silent neuro-endocrine tumours in europe: analysis by tumor origin (2012) (10)
- p53 Hot-Spot Mutational Analysis in Advanced Western Gallbladder Carcinoma (1997) (10)
- Complete bile duct sequestration after liver transplantation, caused by ischemic-type biliary lesions. (2003) (10)
- Identification of novel Cyclooxygenase-2-dependent genes in Helicobacter pylori infection in vivo (2009) (10)
- Expression of EpCam and Villin in Barrett’s Esophagus and in Gastric Cardia (2008) (10)
- New Molecular Aspects for the Diagnosis and Treatment of Neuroendocrine Gastroenteropancreatic Tumors (1994) (10)
- Gastroenteropancreatic neuroendocrine tumours contain a common set of synaptic vesicle proteins and amino acid neurotransmitters. (1993) (10)
- [Endocardial fibrosis in neuroendocrine tumors of the gastroenteropancreatic system]. (2008) (10)
- Requirements for Exocytosis in Permeabilized Neuroendocrine Cells (1994) (10)
- From Basic to Clinical Research in Gastroenteropancreatic Neuroendocrine Tumor Disease – The Clinician-Scientist Perspective (2004) (10)
- ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours (2021) (10)
- New molecular aspects in the diagnosis and therapy of neuroendocrine tumors of the gastroenteropancreatic system. (2000) (10)
- ENETS Consensus Guidelines for the Management of Patients with Rare Metastases from Digestive Neuroendocrine Tumors: Rationale and Working Framework (2010) (9)
- Efficacy and Toxicity of 5-Fluorouracil–Oxaliplatin in Gastroenteropancreatic Neuroendocrine Neoplasms (2020) (9)
- Interferon-gamma inhibits growth of human neuroendocrine carcinoma cells via induction of apoptosis. (2002) (9)
- Ca2+ Channel Properties in Neuroendocrine Tumor Cell Cultures Investigated by Whole‐Cell Patch‐Clamp Technique (2004) (9)
- Some properties of the reaction site for the esterase activity of hemoglobin. (1982) (9)
- Expression and Molecular Regulation of the Cox2 Gene in Gastroenteropancreatic Neuroendocrine Tumors and Antiproliferation of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) (2018) (9)
- Molecular and cell biological aspects of gastroenteropancreatic neuroendocrine tumor disease (1994) (9)
- The amphicrine pancreatic cell line AR42J: a model system for combined studies on exocrine and endocrine secretion (1992) (9)
- Synaptophysin, an Integral Membrane Protein of Vesicles Present in Normal and Neoplastic Neuroendocrine Cells (1987) (9)
- Management of follow-up of neuroendocrine neoplasias. (2016) (8)
- A 7-year-old child with primary tumour localisation in the distal duodenum – new imaging procedures for an improved diagnosis (1997) (8)
- Decrease of natural killer cell activity and monokine production in peripheral blood of patients treated with recombinant tumor necrosis factor (1988) (8)
- Narrow Band Imaging (NBI) Influences the Learning Curve for Conventional Endoscopy - Final Results of a Prospective Randomized Study in the Detection of Colorectal Adenomas (2007) (8)
- 297 Preliminary phase I results of the oral, once-daily anglogenesis inhibitor PTK787/ZK 222584 (PTK/ZK) in combination with chemotherapy for the treatment of metastatic colorectal cancer (2003) (8)
- Isolation, Maintenance, and Characterization of Human Pancreatic Islet Tumor Cells Expressing Vasoactive Intestinal Peptide (2001) (8)
- A Prospective Randomized Study Between Narrow Band Imaging and Conventional Wide-Angle Colonoscopy in the Detection of Colorectal Adenomas (2006) (8)
- PD-L1 – inhibitors in neuroendocrine neoplasia (2021) (8)
- Cerebral processing of auditory stimuli in patients with irritable bowel syndrome. (2006) (8)
- Neuroendocrine Tumors of the Gastroenteropancreatic System: II. Therapeutic Advances (1996) (8)
- Sodium Butyrate Increases Expression of the Coxsackie and Adenovirus Receptor in Colon Cancer Cells (2010) (8)
- Analysis of miR-29 Serum Levels in Patients with Neuroendocrine Tumors—Results from an Exploratory Study (2020) (7)
- New dietary concepts in small bowel transplantation. (2002) (7)
- [Molecules of regulated secretion are differentiation markers of neuroendocrine tumors]. (1997) (7)
- Gastric neuroendocrine neoplasias: manifestations and comparative outcomes (2019) (7)
- Neuroendocrine Tumors of the Gastroenteropancreatic System: I. Diagnostic Advances (1996) (7)
- [Neuroendocrine tumours of the gastrointestinal tract]. (2004) (7)
- Antireflux ‘barriers’: problems with patient recruitment for a new endoscopic antireflux procedure (2009) (7)
- Transforming Growth Factor 1 Stimulates Vascular Endothelial Growth Factor Gene Transcription in Human Cholangiocellular Carcinoma Cells 1 (2003) (7)
- Narrow Band versus White Light HDTV Endoscopic Imaging for Screening Colonoscopy - A Prospective Randomized Trial (Berlin Colonoscopy Project 2, BECOP-2) (2008) (7)
- Sustained partial remission of a metastatic NEN using off-label immunotherapy with pembrolizumab (2019) (7)
- 431 HETEROZYGOUS ALPHA-1 ANTITRYPSIN DEFICIENCY AS AN INHERITED RISK FACTOR IN THE DEVELOPMENT OF CHRONIC LIVER DISEASE (2009) (7)
- Rat Pancreatic AR42J Cells (1994) (7)
- Tumor regression of an ileal carcinoid under the treatment with the somatostatin analogue SMS 201–995 (1988) (7)
- From ENET to ENETS: A Long Odyssey in the Land of Small and Rare Tumors (2004) (7)
- Malnutrition predicts long-term survival in hospitalized patients with gastroenterological and hepatological diseases. (2019) (7)
- Qualitative and quantitative analysis of synapses in Hirschsprung's disease (1998) (6)
- Advanced liver function assessment in patients with intestinal failure on long-term parenteral nutrition. (2020) (6)
- Near-Infrared Confocal Laser Endomicroscopy Detects Colorectal Cancer via an Integrin αvβ3 Optical Probe (2015) (6)
- Automatized Hepatic Tumor Volume Analysis of Neuroendocrine Liver Metastases by Gd-EOB MRI—A Deep-Learning Model to Support Multidisciplinary Cancer Conference Decision-Making (2021) (6)
- [Synaptophysin, chromogranin A and neuron-specific enolase as tumor markers in neuroendocrine tumors of the gastrointestinal tract and lung. An immunohistochemical study]. (1989) (6)
- 381 A Multicenter Analysis of Antiviral Response After One Year of Tenofovir Mono-Therapy in HBV-Monoinfected Patients with Prior Nucleos(t)ide Analog Experience (2008) (6)
- Prospective Quality Assessment of Screening-Colonoscopy in Berlin (Berlin Colonoscopy Project, BECOP-3) (2009) (6)
- Therapeutic and diagnostic implications of the somatostatin system in gastroenteropancreatic neuroendocrine tumour disease. (1999) (6)
- The proline TP53 variant stimulates likely lymphangiogenesis in an orthotopic mouse model of pancreatic cancer (2011) (6)
- [Gastrointestinal neuroendocrine neoplasias: novel individualized therapeutic strategies]. (2011) (6)
- Narrow Band Imaging Versus Conventional Colonoscopy for Screening Colonoscopy in a Private Practice Setting - A Large Prospective Randomized Trial (2008) (6)
- Somatostatin receptor subtypes 2 and 5 mediate inhibition of egg yolk‐induced gall bladder emptying in mice (2010) (6)
- INVESTIGATION OF GASTROINTESTINAL TRANSPORT BY MAGNETIC MARKER LOCALIZATION (2002) (6)
- Expression of functional GABAA receptors in isolated human insulinoma cells. (1998) (6)
- Soluble Urokinase Plasminogen Activator Receptor (suPAR) Concentrations Are Elevated in Patients with Neuroendocrine Malignancies (2020) (6)
- S3-Guideline “Exocrine Pancreatic Carcinoma” 20071 (2008) (6)
- Pancreatic carcinoma (1997) (5)
- Activin a modulates intestinal epithelial cell function in vitro (2000) (5)
- 987 des-acyl Ghrelin Suppresses Food Intake and Body Weight Gain in Adult Obese Zucker Rats (2008) (5)
- The CCKB antagonist CI988 reduces food intake in fasted rats via a dopamine mediated pathway (2013) (5)
- [Effect of ribavirin on dynamics of hepatitis C viremia in interferon alpha-treated patiens with response or no response]. (2000) (5)
- 929 EVALUATION OF SAFETY AND TOLERABILITY OF TENOFOVIR DF (TDF) LONG TERM MONOTHERAPY IN NUCLEOS(T)IDE ANALOGUE EXPERIENCED PATIENTS WITH HBV MONOINFECTION (2009) (5)
- ENETS 2011 Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors (2012) (5)
- Phase I dose-escalation study of novel oral multi-target tumor growth inhibitor (MTGI) ZK 304709 administered daily for 7 days of a 21-day cycle to patients with advanced solid tumors. (2006) (5)
- A Rare Cause of Peripheral Arthralgia in Inflammatory Bowel Disease: Multifocal Osteonecrosis (2014) (5)
- Efficacy, Safety and Pharmacokinetic Results from a Phase II Study of Pasireotide (SOM230) in the Treatment of Patients with Metastatic NETs Refractory or Resistant to Octreotide LAR (2010) (5)
- Multicenter analysis of treatment outcomes for well differentiated grade 3 neuroendocrine tumors (NET G3). (2020) (5)
- Galectin-2, A Potent Modulator of T Cell Apoptosis, Profoundly Downregulates Intestinal Inflammation and Improves Disease Activity in an Experimental Model of Murine Colitis (2006) (4)
- Prognostic relevance of circulating PIGF levels in patients with neuroendocrine tumors. (2012) (4)
- Intestinal plasticity in health and disease (1998) (4)
- Stimulation of Ki‐ras Ribozyme Activity by RNA Binding Protein, NCp7, in Vitro and in Pancreatic Tumor Cell Line, Capan 1 a (1994) (4)
- [Neuroendocrine tumors of the gastrointestinal-pancreatic system. Classification and diagnosis]. (2002) (4)
- Inhibition of L‐Type Calcium Channels by Somatostatins in Human Neuroendocrine Tumor Cells of the Gut (1998) (4)
- [Gastric hamartoma and thyroid gland carcinoma with follicular and neuroendocrine differentiation in Cowden syndrome]. (1996) (4)
- Evaluation of angiotensinogen c.1-44G>A and p.M268T variants as risk factors for fibrosis progression in chronic hepatitis C and liver diseases of various etiologies. (2009) (4)
- Consensus Guidelines for the Standard of Care for Patients with Digestive Neuroendocrine Tumors (2009) (4)
- Poorly differentiated neuroendocrine carcinoma (NEC G3): Prognostic factors and potential novel targets. (2013) (4)
- Neuroendocrine tumors and CUP (2012) (4)
- SPECT/CT Imaging, Biodistribution and Radiation Dosimetry of a 177Lu-DOTA-Integrin αvβ6 Cystine Knot Peptide in a Pancreatic Cancer Xenograft Model (2021) (4)
- 1028 RENAL SAFETY AND ANTIVIRAL EFFICACY OF TENOFOVIR DISOPROXIL FUMARATE (TDF) MONOTHERAPY IN NUCLEOS(T)IDE ANALOGUE REFRACTORY PATIENTS WITH HEPATITIS B VIRUS (HBV) MONO-INFECTION (2010) (4)
- Increased Activity of the Immunoregulatory Enzyme Indoleamine-2,3-Dioxygenase with Consecutive Tryptophan Depletion Predicts Death in Patients with Neuroendocrine Neoplasia (2016) (4)
- UEG Week 2016 Poster Presentations (2016) (4)
- Treatment outcomes of patients with G3 neuroendocrine neoplasms. (2020) (3)
- [Significance of false-positive findings of somatostatin receptor scintigraphy in diagnosis of neuroendocrine tumors of the gastroenteropancreatic system]. (1994) (3)
- HIF–1alpha regulates the bactericidal capacity of phagocytes (2005) (3)
- Megacolon in adulthood after surgical treatment of Hirschsprung's disease in early childhood. (2005) (3)
- Interferon‐α inhibits chromogranin A promoter activity in neuroendocrine pancreatic cancer cells (1999) (3)
- ONLINE LOCALISATION OF A MAGNETIZED CAPSULE FOR INVESTIGATION OF THE GASTROINTESTINAL PASSAGE (2009) (3)
- Gastroenteropancreatic neuroendocrine tumor disease : molecular and cell biological aspects (2004) (3)
- Oxidative stress is a potent activator of the Vascular endothelial growth factor (VEGF) gene in gastric carcinoma cells (2001) (3)
- Percutaneous transhepatic cholangiodrainage under real-time MRI guidance: initial experience in an animal model. (2011) (3)
- [Gastrointestinal oncology - therapy update 2008 / 2009]. (2009) (3)
- Streptozocin-based chemotherapy in patients with advanced pancreatic neuroendocrine tumors. (2014) (3)
- Assessing prognosis of neuroendocrine neoplasms: Results of a collaborative multinational effort including over 10.000 european patients—The ENETS registry. (2018) (3)
- The effect of telotristat etiprate on clinical and biochemical responses in patients with symptomatic carcinoid syndrome: Preliminary results of an ongoing phase II, multicenter, open-label, serial-ascending dose study. (2012) (3)
- 928 EFFECTIVENESS OF TENOFOVIR DF (TDF) MONOTHERAPY IN PATIENTS WITH PRIOR EXPERIENCE TO NUCLEOSIDE/NUCLEOTIDE ANALOGUES BY DIFFERENT PATTERN OF PRE-EXISTING MUTATIONS (2009) (3)
- The ultimate biochemical diagnosis of neuroendocrine gastro-enteropancreatic tumours. (1996) (3)
- [Diagnosis and staging of pancreatic carcinomas]. (2001) (3)
- 1054 Paroxetin, a Selective 5-Hydroxytryptamine RE-Uptake Inhibitor, Increases Postprandial Gastric Volumes and Decreases Symptoms in Patients with Postprandial Distress Syndrome (PDS) Functional Dyspepsia (FD) (2008) (3)
- EVALUATION OF ESOPHAGEAL MOTILITY AND TRANSPORT OF SOLID DRUG DOSAGE FORMS BY MANOMETRY AND MAGNETOMETRY (2009) (2)
- ERCP in the sitting position--an alternative technique with potential benefits (with video). (2010) (2)
- Successful treatment of high-grade pancreatic neuroendocrine neoplasms with everolimus (2017) (2)
- Mo1334 Reasons for the Delay of Diagnosis in Inflammatory Bowel Disease (2013) (2)
- Novel receptor-targeted contrast agents for optical imaging of tumors (2000) (2)
- High rate of Ki‐67 increase in entero‐pancreatic NET relapses after surgery with curative intent (2022) (2)
- Appropriateness of Diagnostic Colonoscopy in the Era of Screening Colonoscopy: Do We Need Better Selection Criteria? (2005) (2)
- Magnetic marker monitoring allows to characterize effects of exogenous factors on esophageal transit of solid drug forms (2002) (2)
- Prospective, Randomized Comparison of Mechanical and Electronic Endoscopic Ultrasound Systems: Image Quality and Performance Parameters (2007) (2)
- [521] MULTIFACTORIAL ANALYSIS OF HOST AND VIRUS RELATED RISK FACTORS FOR THE DEVELOPMENT OF VIRAL RESISTANCE DURING LONG-TERM LAMIVUDINE TREATMENT OF HBV INFECTION OVER UP TO NINE YEARS (2007) (2)
- Abstract 919: Clinical relevance of comprehensive genomic analysis in patients with advanced-stage neuroendocrine neoplasms: Results from the MASTER trial of the German Cancer Consortium (2019) (2)
- Complication of Waldenströem’s macroglobulinaemia following ERCP (2004) (2)
- 820 Keratin 8 Y53H and G61C mutations are no genetic risk factors for developing cryptogenic or noncryptogenic liver disease (2003) (2)
- [Detection of bone metastases in patients with neuroendocrine gastrointestinal tumors]. (1999) (2)
- Long-term efficacy of interferon alpha treatment in chronic hepatitis C. (1998) (2)
- Prognostic factors in gastroenteropancreatic neuroendocrine tumors - A retrospective multivariate analysis (2005) (2)
- Differentiation markers as an aid in the histological diagnosis of small-cell carcinoma of the lung: synopsis of intermediate filament protein and synaptophysin expression. (1988) (2)
- Disease Progression and Disease Prevention in Hepatology and Gastroenterology (2006) (2)
- 415 HIGH PREVALENCE OF CHRONIC HEPATITIS C VIRUS (HCV) INFECTION IN A GERMAN METROPOLITAN AREA: A PROSPECTIVE SCREENING ANALYSING 7683 PATIENTS (2009) (2)
- [Gastroenteropancreatic neuroendocrine/endocrine tumors. Current pathologic-diagnostic view]. (2001) (2)
- 709 LONG-TERM TREATMENT WITH LAMIVUDINE UP TO TEN YEARS: PREDICTIVE VALUE OF HOST AND VIRUS RELATED RISK FACTORS FOR THE DEVELOPMENT OF HBV RESISTANCE (2008) (1)
- 1053 Evaluation of alpha-1-antitrypsin allele frequencies as an inherited risk factor for the development of chronic liver disease of different etiologies (2003) (1)
- Elevated Flt3L Predicts Long-Term Survival in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms (2021) (1)
- Reply to ‘Time for a change and to adopt a novel molecular genomic approach in NETs’ (2019) (1)
- Secretion from pancreatic neuroendocrine cells mediated by small synaptic vesicle analogues (1995) (1)
- 1172 Multifactorial analysis of host and virus related risk factors for the development of viral resistance during long-term lamivudine treatment of HBV infection (2003) (1)
- Synaptophysin: A Major Cell Type-Specific Vesicle Protein of Neuroendocrine Cells (1988) (1)
- 303 Hypoxia-inducible factor 1a promotes gastric cancer chemoresistance via modulation of p53 and NF-κB (2010) (1)
- Access to diagnostics and treatment of neuroendocrine tumors (NETs): The difference between patient perception and reality. (2019) (1)
- Interferon-alpha inhibits chromogranin A promoter activity in neuroendocrine pancreatic cancer cells. (1999) (1)
- Expression of neuronal no synthase in the human gastrointestinal tract (1995) (1)
- 312 Evaluation of angiotensinogen -6G>A and M235T single nucleotide polymorphisms as inherited risk factors for the progression of chronic liver disease of different etiologies (2004) (1)
- 4620 Endoscopic therapy of post-pancreatitic persistent necrosis. (2000) (1)
- Dual function of probiotic E. coli Nissle 1917 (EcN): Inhibition of cell cycle progression for peripheral T cells and pro-apoptotic for mucosal t cells (2003) (1)
- AGTR1 Is Overexpressed in Neuroendocrine Neoplasms, Regulates Secretion and May Potentially Serve as a Target for Molecular Imaging and Therapy (2020) (1)
- Prospective, randomized multicenter trial on the antiproliferative effect of lanreotide, interferon-a and the combination for therapy of metastatic neuroendocrine gep-tumors (2000) (1)
- M1677 Galectin-2 and Galectin-4 Modulate Intestinal Epithelial Cell Function and Intestinal Wound Healing (2008) (1)
- A new experimental model to allow use of clinical-scale endoscopes in small-animal tumor models. (2011) (1)
- Evaluation of the antiproliferative effect of lanreotide or interferon-alpha or the combination of both in the therapy of metastatic neuroendocrine tumors (1998) (1)
- 379 Long-Term Treatment with Lamivudine Up to Ten Years: Predictive Value of Host and Virus Related Risk Factors for the Development of HBV Resistance (2008) (1)
- Influence of guanylin on chromogranin-A release from a human pancreatic carcinoid cell line in vitro (1995) (1)
- [Gastroenteropancreatic neuro-endocrine neoplasms]. (2012) (1)
- Patients with celiac sprue have an increased incidence of white matter brain lesions on cerebral magnetic resonance imaging (MRI) (2006) (1)
- Combination of amantadine with interferon alpha and ribavirin in patients with chronic hepatitis C leads to a reduction of T-helper cell type 2 reactivity (2003) (1)
- 558 Evaluation of alpha-1-antitrypsin allele frequencies as an inherited risk factor for the development of chronic liver disease of different etiologies (2004) (1)
- [Imaging methods in diagnosis of neuroendocrine tumors of the gastrointestinal tract]. (1995) (1)
- Spatial organisation and homeostasis of epithelial lineages at the gastroesophageal junction is regulated by the divergent Wnt mucosal microenvironment (2021) (1)
- Evaluation of an Endocytoscopy System in the Surveillance of Patients with Barrett Esophagus (2006) (1)
- MRI-guided percutaneous transhepatic cholangiodrainage: feasibility study in a porcine model (2014) (1)
- Secretin Receptor as a Target in Gastrointestinal Cancer: Expression Analysis and Ligand Development (2022) (1)
- Hypoxia-Inducible Factor 1 a Determines Gastric Cancer Chemosensitivity via Modulation of p 53 and NFk B (2010) (1)
- Fructose intolerance is frequent in patients with symptoms of irritable bowel syndrome (2002) (1)
- Abundance and distribution of the coxsackie and adenovirus receptor (CAR) in normal and malignant gastric tissue and gastric cancer cell lines (2003) (1)
- Sandostatin® LAR® Leaders Meeting – European Neuroendocrine Tumour Network ENET (2000) (1)
- Abstract 3128: mTOR expression and activity patterns in gastroenteropancreatic neuroendocrine tumors (2010) (1)
- Clinical outcome of personalised treatment guided by genome and transcriptome sequencing in patients with neuroendocrine neoplasms: Updated results from the German NCT/DKTK MASTER trial (2019) (1)
- Tenofovir effectively inhibits viral replication in different patient groups with lamivudine resistant HBV infection (2003) (1)
- [Therapy of pancreatic adenocarcinoma]. (1999) (1)
- AGTR1 is overexpressed in neuroendocrine neoplasms, regulates secretion and may serve as a target for molecular imaging and therapy (2019) (1)
- Correlation between mutations in the E2 region of HCV genotype 1 isolates and responsiveness to IFNα (2000) (1)
- 1304 TH2 CYTOKINE-MEDIATED BILIARY EPITHELIAL CELL (BEC) BARRIER DYSFUNCTION MAY CONTRIBUTE TO IMMUNOGLOBULIN G4 (IGG4) ASSOCIATED SCLEROSING CHOLANGITIS (IAC) (2011) (1)
- Somatostatin inhibits insulin secretion from pancreatic B-cells through modulation of R-type Ca2+ channel activity (2005) (1)
- [Neuroendocrine tumors of the pancreas. Natural history and therapeutic options]. (2003) (1)
- Effect of chemical depolarization on membrane recycling in hypothalamic neurons in culture (1992) (1)
- Contents Vol. 6, 2006 (2007) (0)
- Front & Back Matter (2017) (0)
- Patient-derived tumoroids of advanced high-grade neuroendocrine neoplasms mimic patient chemotherapy responses and guide the design of personalized combination therapies (2022) (0)
- IGF-1 induced activation of L-type Ca2+ channels in human NE primary cell cultures and permanent cell lines is dependent on tyrosine kinase activity (2000) (0)
- HIF-1α promotes gastric cancer chemoresistance via modulation of p53 and NF-κB (2011) (0)
- S3-guideline "exocrine pancreatic carcinoma" 2007 : Results of an Evidence-Based Consensus Conference (13. - 14.10.2006) (2008) (0)
- OWE-15 Advanced liver function assessment in patients with intestinal failure on long-term parenteral nutrition (2019) (0)
- Serum IgG4 and long term outcome in patients with primary biliary cholangitis treated with ursodeoxycholic acid (2016) (0)
- Activin A and its receptors are upregulated in inflammatory bowel diseases (2001) (0)
- LI-cadherin — A marker of intestinal metaplasia and stomach cancer (2000) (0)
- Table of Contents (1987) (0)
- Somatostatin receptor subtype-2 and -3–selective agonists inhibit insulin secretion from INS-1 cells through modulation of the R-type Ca2+ channel activity (2007) (0)
- Prospective Randomized Comparison of a New Re-Opening Endoclip with a Standard Clipping System (2008) (0)
- Human neuroendocrine tumor cells respond to interferon-Γ treatment by induction of apoptosis (2000) (0)
- Subject Index Vol. 90, 2009 (2009) (0)
- Contents Vol. 109, 2019 (2019) (0)
- Contents Vol. 87, 2008 (2008) (0)
- 2347 LEONIS: Long term everolimus observation non-interventional study in pancreatic neuroendocrine tumors (pNET) (2015) (0)
- Helicobacter pylori regulates the human histidine decarboxylase (HDC) promoter through cagA-independent transactivation of a proximal cis-regulatory element (2000) (0)
- 461 Apolipoprotein E polymorphism may protect from hepatitis C virus (HCV) infection (2004) (0)
- 880 THE ROLE OF CD4 T-CELLS IN A MOUSE MODEL OF AUTOIMMUNE HEPATITIS (2008) (0)
- Abstracts of the Scientific Meeting of the Bayliss & Starling Society. Guest Editor: Keith D. Buchanan, Belfast, Northern Ireland (1999) (0)
- Transcriptomic Deconvolution of Neuroendocrine Neoplasms Predicts Clinically Relevant Characteristics (2023) (0)
- TNFα blockade inhibits T cell cycling by NOTCH-1 signaling (2010) (0)
- Contents Vol. 76, 2007 (2007) (0)
- Efficacy of peptide receptor radionuclide therapy (PRRT) as first or second line treatment in advanced metastatic gastric NET (2012) (0)
- S2019 Elevated Serum Ang-2 in Neuroendocrine Tumor Patients Is Associated with Metastatic Spread and Represents a Negative Prognostic Predictor (2008) (0)
- Association of neuroendocrine gastroenteropancreatic tumor disease with multiple endocrine neoplasia type I (1995) (0)
- Pegylated interferon-α stimulates pituitary hormone secretion during long-term therapy (2004) (0)
- Long-Term Failure of Endoscopic Suturing for Gastro-Oesophageal Reflux: A Prospective Follow-Up Study (2005) (0)
- EPITHELIAL-SPECIFIC BLOCKAGE OF THE MYD88-DEPENDENT TLR SIGNALING PATHWAY CONTRIBUTES TO SPONTANEOUS INTESTINAL INFLAMMATION (2008) (0)
- The German neuroendocrine tumor (NET) registry: Quality of data documentation (2007) (0)
- R-spondin-3 induces secretory, antimicrobial Lgr5+ cells in the stomach (2019) (0)
- Subject Index Vol. 87, 2008 (2008) (0)
- [Intraoperative isotope-controlled probe localization after somatostatin receptor scintigraphy of occult neuroendocrine tumors]. (1998) (0)
- Preface (2004) (0)
- S1613: Re-Opening Versus Standard Endoclips for Primary Hemostasis: Preliminary Results of a Prospective, Bicentric, Randomized Study (2010) (0)
- Binding of USF-1/-2 to an upstream CRE-Ebox element is crucial for Helicobacter pylori (Hp)-dependent activation of the COX-2 gene (2001) (0)
- Somatostatin, VIP and new analogs: Endocytosis and effects on secretion in neuroendocrine cells (2003) (0)
- Ulcerative Colitis Response Profiles in Crohn's Disease and Mucosa Reveals Distinctive Immune Proteomic Analysis of the Inflamed Intestinal (2007) (0)
- 481 Serum levels of placental growth factor correlate with survival in patients with neuroendocrine tumors of the pancreas (2010) (0)
- Deletion of somatostatin receptor subtype 2 leads to hyperglucagonemia and impaired glucose control in mice with diet-induced obesity (2007) (0)
- Prevalence of somatostatin receptor subtype 2 in somatostatin receptor positive, gastroenteropancreatic neuroendocrine tumors (1995) (0)
- P157 Reasons for a delayed diagnosis in inflammatory bowel disease (2013) (0)
- Contents Vol. 90, 2009 (2009) (0)
- Differential Ca2+ channel activity in human primary neuroendocrine tumor cell cultures from fore- and midgut tumors (2003) (0)
- Does magnetic resonance imaging provide a new diagnostic tool in IBD patients (2001) (0)
- S2015 Molecular Identification of the SNARE Proteins Syntaxin 3, SNAP 23 and Cellubrevin (VAMP 3) in the Gastrointestinal Mucosa, Hepatopancreatic Tissues and Neuroendocrine Tumors (2008) (0)
- Functional imaging tests and CT scan: Detection of new metastases and clinical usefulness in digestive neuroendocrine neoplasms follow-up. (2016) (0)
- Contents Vol. 6, 2019 (2019) (0)
- Subject Index Vol. 80, 2004 (2005) (0)
- Prognostic relevance of the novel TNM-classification system for neuroendocrine tumors of foregut origin (2007) (0)
- Somatostatin receptor subtype 2 inhibits glucagon secretion and regulates glucose homeostasis (2007) (0)
- The interaction of erythrocyte ghosts and vesicles with chromatographed hemoglobin ( Hb ) (2001) (0)
- Contents Vol. 97 (2013) (0)
- ENETS Newsletter (2004) (0)
- Chemotherapy of metastatic neuroendocrine gas-troenteropancreatic tumors with streptozotocin and 5-fluorouracil (2000) (0)
- cAMP-dependent signaling pathways regulate the human histidine decarboxylase promoter through activation of MAPK/ERK-cascades in gastric cancer cells (1998) (0)
- Microarray analysis of mucosal gene expression profiles during gastric H. pylori infection (2002) (0)
- 592 Enteral and Parenteral Nutrition Modulates Intestinal Permeability and Systemic Inflammation (2008) (0)
- Front & Back Matter (2012) (0)
- The α5β1 fibronectin receptor sensitizes carcinoma cells to Galectin–1 mediated anoikis (2005) (0)
- Use of New Technology, But Not Study Participation Increases Adenoma Detection: A Comparative Study On 4700 Screening Colonoscopies (Berlin Colonoscopy Project 4, BECOP-4) (2009) (0)
- Erratum. (2020) (0)
- THE PRESENCE OF ESCHERICHIA COLI BACTERIOPHAGES IN HUMAN STOOL OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE (2007) (0)
- Esophageal transit of solid drug forms depends on body position, swallowing volume and pharyngeal propulsion velocity — a magnetic marker monitoring (MMM) study (2003) (0)
- Interferon γ mediated induction of apoptosis in primary human neuroendocrine tumor cells (2001) (0)
- A comparative study to assess the diagnostic value of transabdominal ultrasound and magnetic resonance imaging in patients with inflammatory bowel diseases (2003) (0)
- Editorial Board Vol. 26, 2010 (2010) (0)
- Expression and molecular control of the lymphangiogenic and prometastatic vegf-d gene in gastric cancer tissues and cell lines (2003) (0)
- Ursodeoxycholic acid normalizes the 15 years survival in German patients with primary biliary cirrhosis and normal serum bilirubin levels at baseline (2009) (0)
- MALNUTRITION PREDICTS LONG-TERM MORTALITY IN HOSPITALIZED GASTROENTEROLOGICAL PATIENTS (2017) (0)
- Comparison of Screening and Diagnostic Colonoscopy in a Multicenter Outpatient Setting: Is There a Difference in Relevant Findings? (2005) (0)
- MON-PO402: Systemic Anti-Cancer Therapies Impair the Nutritional Status of Neuroendocrine Tumor Patients – A Pilot Study (2019) (0)
- Foreword (2012) (0)
- Gastric neuroendocrine neoplasias – Outcome predictors – ENETS staging and grading system and treatment (2015) (0)
- patients with advanced neuroendocrine tumors refractory or resistant to (2012) (0)
- 320 VEGF-D Promotes Tumor Growth and Lymphatic Spread in Hepatocellular Carcinoma (2008) (0)
- ÏÎ ÌÀÒÅÐÈÀËÀÌ ÊËÈÍÈ×ÅÑÊÈÕ ÐÅÊÎÌÅÍÄÀÖÈÉ ÏÎ ÂÅÄÅÍÈÞ ÁÎËÜÍÛÕ Ñ ÄÈÔÔÅÐÅÍÖÈÐÎÂÀÍÍÛÌÈ ÍÅÉÐÎÝÍÄÎÊÐÈÍÍÛÌÈ ÎÏÓÕÎËßÌÈ ÈËÅÎÅÞÍÀËÜÍÎÉ ËÎÊÀËÈÇÀÖÈÈ Áåëüöåâè÷ Ä.Ã., Ìåëüíè÷åíêî Ã.À. (2009) (0)
- Outcome predictors of gastrinomas: The role of ENETS staging, grading and interdisciplinary treatment (2014) (0)
- Insulin sensitivity (IS) is normal but intra-abdominal fat increases during therapy of acromegaly with pegvisomant (PT) (2006) (0)
- 487 The axon guidance molecule Slit2 regulates the motility of neuroendocrine cancer cells (2010) (0)
- Curative resection in digestive neuroendocrine neoplasms: Recurrence-free survival rate and definition of a risk score for recurrence. (2016) (0)
- Expression des Tight junction-Proteins Cingulin im humanen Gastrointestinaltrakt und korrespondierenden Karzinomen–Ein neuer Marker des epithelialen Differenzierungsgrades? (2005) (0)
- A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors (2018) (0)
- Author Index and Subject Index (2001) (0)
- Activin a stimulates VEGF gene transcription in human hepatocellular carcinoma cells (2003) (0)
- Activation Apoptosis with Distinct Profile of Caspase Human Galectin-2 : Novel Inducer of T Cell (2004) (0)
- [Endoscopic therapy of acute and chronic pancreatitis]. (2005) (0)
- DRAFT: RAMSETE trial of everolimus (RAD001) in the treatment of silent (nonfunctioning) advanced neuroendocrine tumors. (2010) (0)
- Contents Volume 4, 2017 (2018) (0)
- SUN-P133: Malnutrition Screening of Gastroenterological Patients: The Relationship between Subjective Global Assesement, Bioelectrical Impedance Analysis and Surrogate Parameters (2016) (0)
- 828 Glucocorticoids Stimulate Tight Junction Sealing in Intestinal Epithelial Cells By Modulating Expression of Claudin-2 and Claudin-4 (2008) (0)
- Dynamic of development of lamivudine-resistant mutants of HBV (YMDD mutations) (2003) (0)
- An outbreak of carbapenem-resistant OXA-48 – producing Klebsiella pneumonia associated to duodenoscopy (2015) (0)
- 6981 Endoscopic and surgical management of biliary lesions after laparoscopic cholecystectomy (lce). (2000) (0)
- Subject Index Vol. 91, 2010 (2010) (0)
- [Somatostatin receptor scintigraphy and endoscopic ultrasound for the diagnosis of insulinoma and gastrinoma]. (1995) (0)
- CT-gestütze Brachytherapie (Afterloading) als therapeutische Option inoperabler hepatozellulärer Karzinome (HCC) (2004) (0)
- Insulin-like growth factor I stimulates chromogranin a secretion in a human pancreatic carcinoid cell line via PI3-kinase (2000) (0)
- Endoscopic Removal of Embedded Self-Expanding Esophageal Metal Stents (2005) (0)
- Molecular and Cell Biological Aspects of Gastroenteropancreatic Neuroendocrine Tumor Disease. Conference proceedings. Berlin, Germany, November 3-7, 1993. (1994) (0)
- S1704 TNF-α Blockade Inhibits Mucosal T Cell Activation and Cell Cycling and Induces B Cell Apoptosis (2009) (0)
- Preface (1998) (0)
- Rapid and prolonged closure of Crohn's disease fistulas under intensified immunosuppressive therapy (2000) (0)
- Three-dimensional high resolution monitoring of gastroduodenal transit using magnetic markers (1998) (0)
- 534 Complement factor 5 is no genetic risk factor for the progression of liver fibrosis in chronic hepatitis C infection (2006) (0)
- Heucobacter pylori activates the human histidine decarboxylase promoter through mapk-ERK signaling pathways independent of cagA-pathogenicity island-encoded virulence factors (2000) (0)
- 683 INEFFICIENT PRIMING OF CD4 T-CELLS BY LIVER-DERIVED ANTIGEN IN A MOUSE MODEL OF AUTOIMMUNE HEPATITIS (2009) (0)
- Papillary stenosis in liver-transplanted patients (1998) (0)
- Development of a training model for PTCD under MRI real-time guidance (MRI-PTCD) (2009) (0)
- Expression of Transient Receptor Potential (TRP) channels of the M-family in cultured human neuroendocrine tumor (NET) cells (2004) (0)
- Transport routeforsynaptobrevin viaa novel pathwayofinsertion intotheendoplasmic reticulum membrane (1995) (0)
- 264 Establishment of a targeted fluorescence guided colonoscopy for a xenograph orthotopic colorectal cancer model (2010) (0)
- Synaptophysin: A novel broad marker polypeptide for a variety of neuroendocrine tumors (1987) (0)
- P304 - Galectin-2 and galectin-4 modulate intestinal wound healing, induce T cell apoptosis and thus ameliorate intestinal inflammation in an experimental model of murine colitis (2009) (0)
- Success of Endoscopic Therapy in Traumatic Bile Duct Lesions (2004) (0)
- Positive somatostatin receptorscintigraphy correlates withthepresenceofsomatostatin receptorsubtype 2 (1996) (0)
- Subject Index Vol. 6, 2006 (2007) (0)
- The antitumor and antimetastasis effect of the oral Multi-target Tumor Growth Inhibitor™, ZK 304709, in pancreatic tumor xenografts (2006) (0)
- Neuroendocrine midgut tumours : part 2: Therapy (2004) (0)
- 995 Proteomic Analysis Separates Barrett's Esophagus and Esophageal Adenocarcinoma from Healthy Controls By Distinct T Cell Populations (2008) (0)
- Therapie der Lamivudin-resistenten Hepatitis B Virus (HBV)-Infektion mit Tenofovir Disoproxil Fumarat: Wirksamkeit und Verträglichkeit bei Patienten mit bzw. ohne Immunsuppression (2015) (0)
- Pegylated interferon-α augments basal and stimulated GH and PRL secretion during long-term therapy in patients with chronic hepatitis C (2005) (0)
- Abstract 1761: Class I HDAC expression patterns in gastroenteropancreatic neuroendocrine tumors (2010) (0)
- Phase II pilot trial of preoperative high-dose chemotherapy in patients with malignant tumors of the upper gastrointestinal tract. (1996) (0)
- K-Ras downregulation is required for p16INK4a mediated anoikis induction in Capan-1 pancreatic cancer cells (2003) (0)
- T1661 Peripheral Injection of CCK-8s Activates Cart Positive Neurons in the Paraventricular Nucleus of the Hypothalamus (2009) (0)
- Clinical characterization and long-term documentation of cryptogenic cirrhosis before and after liver transplantation (2001) (0)
- [575] PREDICTION OF TREATMENT RESPONSE TO 72 WEEKS OF PEGYLATED INTERFERON ALFA-2a PLUS RIBAVIRIN FOR CHRONIC HEPATITIS C AFTER LIVER TRANSPLANTATION (2007) (0)
- In memoriam Dr. med. Rainer E. Hintze * 23.07.1938 † 26.06.2015 (2015) (0)
- Tacrolimus (FK506) is safe and effective in patients with refractory extraintestinal manifestations of inflammatory bowel disease (2006) (0)
- 912 APOLIPOPROTEIN E4 ALLELE PROTECTS FROM CHRONIC HCV INFECTION (2012) (0)
- Anti-Reflux “Barriers” - What Is the Current Market for a New Endoscopic Antireflux Method? Experiences from the Initial Study Recruitment in a Tertiary Referral Center (2007) (0)
- Inhibition of R-type Ca2+-channel activity reduces chromogranin a secretion in human neuroendocrine tumor bon cells (2003) (0)
- Orexin-A differentially regulates gene expression and secretion of insulin and glucagon (2005) (0)
- Near-infrared fluorescent somatostatin receptor analogs as tracer mofecules for tumor diagnosis (2001) (0)
- S1771 TNF-α Blockers Inhibit T Cell Cycling by Notch-1 Signalling (2010) (0)
- 462 Influence of interleukin 12B gene (IL 12B) polymorphism in spontaneous or treatment-induced recovery from hepatitis C (HCV) infection (2004) (0)
- 18 Differential priming of T cells by antigens expressed in hepatocytes and cholangiocytes in animal models of autoimmune hepatitis and cholangitis (2006) (0)
- Postprandial abdominal pain, megaloblastic anaemia, and severe weight loss in an 80 year old man (2005) (0)
- 4616 Biliary complications after liver transplantation. long term study over 9 years considering 1,017 liver grafts. (2000) (0)
- HIF-1α is essential for inflammation-associated colon carcinogenesis (2011) (0)
- The German neuroendocrine tumor registry: Centres and epidemiology of neuroendocrine tumors (2007) (0)
- 4681 Endoscopic management of psc patients suffering from dominant bile duct strictures. (2000) (0)
- Acknowledgement of Reviewers 2017 (2018) (0)
- Dynamics of lamivudine-resistant mutants (YMDD mutations) development during long-term therapy for chronic hepatitis B (2003) (0)
- NSAIDs inhibit growth of human neuroendocrine tumor cells via G1 cell cycle arrest (2003) (0)
- P198 Galectin-4 Induces T Cell Apoptosis and Ameliorates Intestinal Inflammation in an Experimental Model of Murine Colitis (2007) (0)
- S2032 Defining Carcinoma Risk in Barrett Patients - Known Risk Factors May Be Less Important (2008) (0)
- Intratumoral dendritic cells and T cells predict survival in gastroenteropancreatic neuroendocrine neoplasms. (2023) (0)
- Preface (1994) (0)
- DNA-ploidity predicts clinical outcome after liver resection due to cholangiocarcinoma (2001) (0)
- Contents Vol. 80, 2004 (2005) (0)
- Acute renal failure in carcinoid syndrome crisis (2004) (0)
- 48 Conditional loss of HIF-1α delays liver regeneration and aggravates toxicity after carbon tetrachloride administration (2004) (0)
- PP158-MON SYSTEMATIC NUTRITIONAL STATUS ASSESSMENT, PREVALENCE OF MALNUTRITION AND CLINICAL OUTCOME IN PATIENTS WITH SHORT BOWEL SYNDROME (2013) (0)
- Patch-Clamp investigations of voltage-dependent Ca2+ channel currents in endocrine pancreatic insulin-secreting β-cells (INS-1) and glucagon-secreting α-cells (InR1-G9) (2004) (0)
- 582 Dexamethasone Stimulates Tight Junction Sealing in Intestinal Epithelial Cells by up Regulating Claudin-4 Expression via a Pathway Involving MKP-1 and p38 (2010) (0)
- Meta-analysis of ISDR mutations and interferon-alpha (IFNA) sensitivity in patients with chronic hepatitis C virus (HCV) genotype 1B infection (2003) (0)
- Influence of therapy with IFN alpha 2A and consensus-IFN (IFN alpha-con) on the T-helper cell type 1 and type 2 reactivity in patients with hepatitis C (2003) (0)
- Microarray analysis of epithelial gene expression profiles during gastric Helicobacter pylori infection (2003) (0)
- [26] ANTIGEN PRESENTATION BY BONE-MARROW DERIVED ANTIGEN PRESENTING CELLS IS REQUIRED FOR EFFECTIVE T-CELL PRIMING IN AN ANIMAL MODEL OF AUTOIMMUNE LIVER DISEASE (2007) (0)
- W1160 Adalimumab Prevents TNFα Induced Barrier Disruption in An In Vitro Model (2008) (0)
- 274 Bioluminescence imaging for monitoring tumor growth of GI-tract tumors (2010) (0)
- Significance of elevated IL8 levels in patients with chronic hepatitis C in comparison with patients with liver diseases of different origin (2003) (0)
- The MEN-1 gene product is overexpressed in neuroendocrine tumor (2000) (0)
- 7264 Clinical outcome of percutaneous-duodenal bile duct stent of the yamakawa type. (2000) (0)
- Current status of the diagnosis and treatment of hereditary and sporadic neuroendocrine tumors of the gastroenteropancreatic system : European Neuroendocrine Tumor Society (ENETS), Budapest, March 2004 (2004) (0)
- 37th Annual Meeting of the American Pancreatic Association and 13th Meeting of the International Association of Pancreatology. November 1–4, 2006, Chicago, Ill. (2007) (0)
- 689 des-acyl Ghrelin Inhibits the Orexigenic Effect of Peripherally Injected Ghrelin (2008) (0)
- Somatostatin receptor subtype-2 and -3 selective agonists inhibit insulin secretion from INS-1 cells through modulation of the R-type Ca 2+ channel (2007) (0)
- , via Toll-Like Receptor 2 Signaling Modulates T-Cell Cycling and Expansion Nissle 1917 Distinctively Escherichia coli (2005) (0)
- Contents Vol. 5, 2018 (2019) (0)
- Evaluation of a Prototype 22-Gauge Biopsy Needle for EUS-FNA: A Randomized, Prospective Comparison of Cytology and Histology Yield (2007) (0)
- Endoscopic Or Surgical Resection of Submucosal Adenocarcinoma of the Esophagus Or Stomach? A Decision Analysis (2006) (0)
- Educational aspects of molecular medicine in basic science and clinical training (2002) (0)
- 71 ENHANCED PATTERN RECOGNITION SIGNALING IN HUMAN CHOLANGIOCYTES CONTRIBUTES TO CHRONIC INFLAMMATION IN END-STAGE CHRONIC INFLAMMATORY LIVER DISEASE (2009) (0)
- Dynamic anorectal endoluminal ultrasonography detects enteroceles (1998) (0)
- Sa1389 Clinical Usefulness of Functional Imaging Tests in the Follow-Up of Digestive Neuroendocrine Neoplasms (2016) (0)
- 145 Enhanced TLR Signaling Breaks Endotoxin Tolerance in Human Biliary Epithelial Cells in END-Stage Chronic Inflammatory Liver Disease (2009) (0)
- Clinical information allows differentiation between pancreatic carcinoma an chronic pancreatitis (2003) (0)
- Influence of mental stress and rectal distension on tonic and phasic motor activity of the left colon (1998) (0)
- Announcement and Erratum (1999) (0)
- Low-density lipoprotein receptor polymorphisms are associated with spontaneous and treatment-induced recovery from hepatitis C virus infection (2008) (0)
- Endoscopic Mucosal Resection of Neoplasia in the Esophagus and Gastroesophageal Junction: Impact On Histological Diagnosis and Further Management (2007) (0)
- T1180 MRI-Guided Percutaneous Transheptic Cholangio Drainage (MRI-PTCD): Feasibility Study Using a Pig Model (2009) (0)
- Peripheral blood plasmocytoid (PDC) and myeloid dendritic cells (MDC) are significantly reduced in active inflammatory bowel disease (2003) (0)
- Cholangiocellular Carcinoma Cells Endothelial Growth Factor Gene Transcription in Human 1 Stimulates Vascular β Transforming Growth Factor Updated (2003) (0)
- Contents Vol. 91, 2010 (2010) (0)
- De novo expression of vascular endothelial growth factor and its receptors in human pancreatic cancer: Evidence for a novel autocrine mitogenic loop (2000) (0)
- 1096 DENDRITIC CELLS BUT NOT KUPFFER CELLS ARE REQUIRED FOR THE ACTIVATION OF SELF-REACTIVE CD8 T-CELLS IN THE LIVER (2010) (0)
- Molecular Aspects of Potential New Therapies for Neuroendocrine Tumors (2013) (0)
- Subject Index Vol. 76, 2007 (2007) (0)
- S1857 Peripheral Obestatin Has No Effect On Fos Induction in Hypothalamic and Brainstem Nuclei Which Are Involved in Feeding Behavior (2008) (0)
- Ga-68 somatostatin receptor PET/CT in the management of neuroendocrine tumors of the lungs (2012) (0)
- Rapid and prolonged closure of Crohn's disease fistulas with intensified immunosuppressive therapy (2000) (0)
- Orexin-A inhibits glucagon secretion and proglucagon gene expression (2007) (0)
- Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors. Authors' reply (2004) (0)
- Vasoactive intestinal peptide receptor scintigraphy in patients with pancreatic tumors: A clinical study (1998) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Bertram Wiedenmann?
Bertram Wiedenmann is affiliated with the following schools:
